期刊文献+

自制HBV—DNA质控物的稳定性评价 被引量:2

Evaluation of the Stability of Self-made Quality Control Substances of HBV-DNA
下载PDF
导出
摘要 目的制备HBV—DNA荧光定量PCR检测质控物,评价其稳定性。方法收集HBv_DNA阳性新鲜血清及HBV—DNA阴性新鲜血清,去除其他阳性指标(HAV—Ab,HCV-Ab,HIV—Ab和梅毒抗体)的标本后,分别充分混合,使用HBV-DNA阴性混合血清将HBv_DNA阳性混合血清稀释至一定浓度后,灭活、分装,随机分为5组,即A,B,C,D和E组。A组:立即在最佳条件下和常规条件下,应用HBV—DNA荧光实时定量PCR检测试剂盒分别检测20次;B组:放置4℃冰箱48h后检测;C组:放置4℃冰箱48h后,再置-20℃冷冻24h后复融检测;D组:在满足C组条件后,置-20℃冰箱冷冻24h后二次复融检测;E组:置-20℃保存12个月复融后检测。各组质控物均在常规条件下检测20次,分别计算各组均值的对数值、标准差和变异系数。结果A,B,C,D,E组HBV-DNA质控物均值的对数值分别为4.611,4.590,4.600,4.638和4.571,经方差分析F-2.32〈F0.05(4,95)2.47,P〉0.05,均值的对数值之间差异无统计学显著性意义;标准差分别为0.211,0.198,0.221,0.191和0.214;变异系数分别为4.5%,4.3%,4.8%,4.1%和4.6%,标准差、变异系数之间差异很小。结论HBV—DNA质控物制备简单,稳定性良好,适合临床检验中心进行室间质评(EQA)或现场EQA。 Objective To prepare quality control substances of HBV-DNA used in real-time quantitative polymerase chain re- action(real-time PCR) ,and observed the stability of it. Methods Collecting HBV-DNA positive and negative fresh serum of specimens. Specimens with positive indexes (HAV-Ab, HCV-Ab, HIV-Ab and syphilis antibody) were removed, then re- spectively mixed all the serums well. HBV-DNA positive mixed serums were diluted by using HBV-DNA negative mixed se- rums, then inactivated, s ubpackage, randomly divided into 5 groups, namely group A, group B, group C, group D and group E. Group A: immediately detecting the serums 20 runs respectively by diagnostic kit for quantification of quantification of HBV-DNA under optimal conditions and routine conditions. Group B: placed the serums in 4℃ refrigerator then detecting in 48 hours. Group C: placed the serums in 4℃ refrigerator for 48 hours, then in -20℃ for 24 hours then thawed. Group D: to meet the conditions of C group,in - 20℃ for 24 hours then thawed. Group E: in - 20℃ for 12 months then thawed. Each group was detected 20 runs respectively under the routine conditions. Logarithms of mean value of the groups, standards de- viation and coefficients of variation were calculated. Results The logarithms of mean value of the five groups were 4. 611, 4. 590,4. 600,4. 638 and 4. 571 respectively. By using analysis of variance,F=2.32〈F0.05 (4,95)2.47,P〉0.05,the differ- ence among the logarithms of the mean values had no significance. Standard deviations were 0.211,0. 198,0.221,0.191 and 0. 214 respectively. Coefficients of variability were respectively 4.5%, 4.3%, 4.8%, 4.1% and 4.6%. There was little difference among standard deviations, and coefficients of variability also. Conclusion Quality control substances of tfBV- DNA have simple preparation,good stability,and are suitable for external quality assessment (EQA) or spot EQA.
出处 《现代检验医学杂志》 CAS 2012年第5期158-160,共3页 Journal of Modern Laboratory Medicine
基金 徐州市科学技术局科技项目(项目编号XF11C031).
关键词 HBV—DNA 质控物 室间质量评价 Kcywords: HBV-DNA the stability of quality control substance external quality assessment
  • 相关文献

参考文献6

二级参考文献39

  • 1李金明.聚合酶链反应临床应用的优越性和局限性[J].中华检验医学杂志,2005,28(3):225-227. 被引量:75
  • 2李金明.血液感染性疾病标志物筛检中应重视的若干问题[J].中华检验医学杂志,2005,28(6):569-571. 被引量:37
  • 3彭建明,李金明.定量PCR测定数据处理数学模型研究进展[J].国外医学(临床生物化学与检验学分册),2005,26(7):449-451. 被引量:4
  • 4袁继炎,周学锋,杨晓进.经外环途径治疗小儿腹股沟疝[J].临床外科杂志,1995,3(6):309-310. 被引量:23
  • 5李金明.临床实验室分子诊断的标准化[J].中华检验医学杂志,2006,29(6):483-486. 被引量:29
  • 6Libeer JC, Baadenhuijsen H, Fraser CG, et al. Characterization and classification of external quality assessment schemes (EQA) according to objectives such as evaluation of method and participant bias and standard deviation. Eur J Clln Chem Clin Biochem, 1996,34:665-678.
  • 7Miller WG.Specimen materials, target values and commutability for external quality assess( proficiency testing) schemes. Chin Chim Acta,2003 327:25 -37.
  • 8Ross JW, Miller WG, Myers GL, et al. The accuracy of laboratory measurements in clinical chemistry, a study of 11 routine chemistry analytes in the college of american pathologists chemistry survey with fresh frozen serum, definitive methods and reference methods. Arch Pathol Lab Med, 1998,122:587-608.
  • 9Ehrmeyer SS, Laessig RH.Has compliance with CLIA requirements really improved quality in US clinical laboratory?.Clin Claim Aeta,21304,346:37-43.
  • 10Shahangian S.Proficiency testing in laboratory medicine:uses and limitations. Arch Pathol Lab Med, 1998,122 : 15-30.

共引文献94

同被引文献10

引证文献2

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部